http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535784-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 |
| filingDate | 2008-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2010535784-A |
| titleOfInvention | Method for the synthesis of compounds useful for the treatment of hepatitis C |
| abstract | The present invention generally relates to ((1S) -1-(((2S) -2- (5- (4 '-(2-((2S) -1-((2S) -2-((methoxycarbonyl)) Amino) -3-methylbutanoyl) -2-pyrrolidinyl) -1H-imidazol-5-yl) -4-biphenylyl) -1H-imidazol-2-yl) -1-pyrrolidinyl) carbonyl) -2-methylpropyl ) It relates to a method for the synthesis of methyl carbamate dihydrochloride. The present invention also generally relates to intermediates useful in the present methods. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012522003-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010535785-A |
| priorityDate | 2007-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.